Celaidtx
2 known investors
Celaid Therapeutics develops hematopoietic stem cell expansion technology, including a method to replace albumin with polyvinyl alcohol and to expand human hematopoietic stem cells ex vivo in large quantities. The company applies this technology to stem cell transplantation and gene therapy for blood cancers such as leukemia and other blood and genetic diseases.
Founders & leadership
NA
Nobuyuki ArakawaCo-founder & Representative Director, President & CEO
YI
Yusuke InoueDirector, COO & CFO
AU
Asako UchiyamaDirector, CDO (Chief Development Officer)
MW
Motoo WatanabeCo-founder / Advisor (former Chairman & CSO)
HN
Hiromitsu NakauchiCo-founder
MS
Masatoshi SakuraiCo-founder